These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 27055064)

  • 21. [EVALUATION STANDARD OF EXTERNAL QUALITY ASSESSMENT PROGRAMME FOR DRUG SUSCEPTIBILITY TESTING OF MYCOBACTERIUM TUBERCULOSIS IN JAPANESE LABORATORIES: PROFICIENCY TESTING IN 2004-2010].
    Kekkaku; 2015 Apr; 90(4):481-90. PubMed ID: 26489152
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of a worldwide EQA scheme for complex clonality analysis of clinical lymphoproliferative cases demonstrates a learning effect.
    Keppens C; Boone E; Gameiro P; Tack V; Moreau E; Hodges E; Evans P; Brüggemann M; Carter I; Lenze D; Sarasquete ME; Möbs M; Liu H; Dequeker EMC; Groenen PJTA
    Virchows Arch; 2021 Aug; 479(2):365-376. PubMed ID: 33686511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Mycobacterial tests].
    Takashima T; Higuchi T
    Kekkaku; 2008 Jan; 83(1):43-59. PubMed ID: 18283915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Reference Laboratory Network: five rounds of proficiency testing, 1994-1998.
    Laszlo A; Rahman M; Espinal M; Raviglione M;
    Int J Tuberc Lung Dis; 2002 Sep; 6(9):748-56. PubMed ID: 12234129
    [TBL] [Abstract][Full Text] [Related]  

  • 25. External Quality Assessment of Bacterial Identification and Antimicrobial Susceptibility Testing in African National Public Health Laboratories, 2011-2016.
    Perovic O; Yahaya AA; Viljoen C; Ndihokubwayo JB; Smith M; Coulibaly SO; De Gouveia L; Oxenford CJ; Cognat S; Ismail H; Frean J
    Trop Med Infect Dis; 2019 Dec; 4(4):. PubMed ID: 31847247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antimicrobial susceptibility testing of Mycobacterium tuberculosis (EUCAST document E.DEF 8.1)--report of the Subcommittee on Antimicrobial Susceptibility Testing of Mycobacterium tuberculosis of the European Committee for Antimicrobial Susceptibility Testing (EUCAST) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID).
    Drobniewski F; Rüsch-Gerdes S; Hoffner S;
    Clin Microbiol Infect; 2007 Dec; 13(12):1144-56. PubMed ID: 17727670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Revisiting susceptibility testing in MDR-TB by a standardized quantitative phenotypic assessment in a European multicentre study.
    Cambau E; Viveiros M; Machado D; Raskine L; Ritter C; Tortoli E; Matthys V; Hoffner S; Richter E; Perez Del Molino ML; Cirillo DM; van Soolingen D; Böttger EC
    J Antimicrob Chemother; 2015 Mar; 70(3):686-96. PubMed ID: 25587993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Migration-related tuberculosis: epidemiology and characteristics of tuberculosis cases originating outside the European Union and European Economic Area, 2007 to 2013.
    Ködmön C; Zucs P; van der Werf MJ
    Euro Surveill; 2016; 21(12):. PubMed ID: 27039665
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TB management in the European Union/European Economic Area: a multi-centre survey.
    Sotgiu G; Rosales-Klintz S; Centis R; D'Ambrosio L; Verduin R; Correia AM; Cirule A; Duarte R; Gadzheva B; Gualano G; Kunst H; Palmieri F; Riekstina V; Stefanova D; Tiberi S; van der Werf MJ; Migliori GB
    Int J Tuberc Lung Dis; 2021 Feb; 25(2):126-133. PubMed ID: 33656424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Experience establishing tuberculosis laboratory capacity in a developing country setting.
    Paramasivan CN; Lee E; Kao K; Mareka M; Kubendiran G; Kumar TA; Keshavjee S; Satti H; Alabi G; Raviglione M; Roscigno G
    Int J Tuberc Lung Dis; 2010 Jan; 14(1):59-64. PubMed ID: 20003696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of migration within the European Union/European Economic Area on the distribution of tuberculosis, 2007 to 2013.
    Hollo V; Kotila SM; Ködmön C; Zucs P; van der Werf MJ
    Euro Surveill; 2016; 21(12):. PubMed ID: 27035746
    [TBL] [Abstract][Full Text] [Related]  

  • 32. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. External quality assessment of AFB smear microscopy performances and its associated factors in selected private health facilities in Addis Ababa, Ethiopia.
    Mosissa L; Kebede A; Mindaye T; Getahun M; Tulu S; Desta K
    Pan Afr Med J; 2016; 24():125. PubMed ID: 27642463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the microscopic observation drug susceptibility assay for the rapid detection of MDR-TB and XDR-TB in China: a prospective multicentre study.
    Huang Z; Qin C; Du J; Luo Q; Wang Y; Zhang W; Zhang X; Xiong G; Chen J; Xu X; Li W; Li J
    J Antimicrob Chemother; 2015 Feb; 70(2):456-62. PubMed ID: 25266071
    [TBL] [Abstract][Full Text] [Related]  

  • 35. External quality assessment in resource-limited countries.
    Carter JY
    Biochem Med (Zagreb); 2017 Feb; 27(1):97-109. PubMed ID: 28392732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. External Quality Assessment of Sputum Smear Microscopy in Tuberculosis Laboratories in Sughd, Tajikistan.
    Chang E; Luelmo F; Baydulloeva Z; Joncevska M; Kasymova G; Bobokhojaev O; Mohr T
    Cent Asian J Glob Health; 2015; 4(2):230. PubMed ID: 29138725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. External quality assessment: best practice.
    James D; Ames D; Lopez B; Still R; Simpson W; Twomey P
    J Clin Pathol; 2014 Aug; 67(8):651-5. PubMed ID: 24621574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analytical performance specifications for external quality assessment - definitions and descriptions.
    Jones GRD; Albarede S; Kesseler D; MacKenzie F; Mammen J; Pedersen M; Stavelin A; Thelen M; Thomas A; Twomey PJ; Ventura E; Panteghini M;
    Clin Chem Lab Med; 2017 Jun; 55(7):949-955. PubMed ID: 28593915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. First proficiency testing of second-line anti-tuberculosis drug susceptibility testing in 12 provinces of China.
    Jiang GL; Chen X; Song Y; Zhao Y; Huang H; Kam KM
    Int J Tuberc Lung Dis; 2013 Nov; 17(11):1491-4. PubMed ID: 24125456
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multicenter feasibility study to assess external quality panels for molecular diagnostics for tuberculosis in China.
    Du J; Shu W; Liu Y; Wang Y; Zhan Y; Yu K; Gao J; Li L; Pang Y
    Eur J Clin Microbiol Infect Dis; 2020 Feb; 39(2):339-343. PubMed ID: 31901114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.